RESULTS: There were no differences in echocardiographic measurements between TAVR and SAVR at baseline. In the SAVR group, TAPSE was reduced after 3 months (2.4 ± 0.5 cm vs 1.6 ± 0.4 cm; P < 0.001), and 12 months (2.4 ± 0.5 cm vs 1.7 ± 0.4 cm; P < 0.001). RVFAC was reduced after 3 months (44% ± 11% vs 39% ± 10%; P = 0.001), but recovered at 12 months (43% ± 10%; P = 0.39). AVPD lateral increased during follow-up (1.4 ± 0.3 cm vs 1.6 ± 0.4 cm (P = 0.001) and 1.7 ± 0.4 cm, respectively; P < 0.001), whereas AVPD medial remained stable (baseline vs 3 months: P = 0.06 and baseline vs 12 months: P = 0.59). In the TAVR group, all echocardiographic measures remained unchanged from baseline to 12 months postoperatively. We found no association between echocardiographic changes and NYHA class.
INTRODUCTION
Echocardiographic evaluation of right ventricular (RV) function has posed difficulties, due to the complex geometry and a systolic motion pattern of both longitudinal and transverse contraction [1] . There is no consensus on the optimal method for RV assessment, but one of the most reproducible and reliable transthoracic echocardiographic (TTE) measures of RV longitudinal systolic function is tricuspid annular plane systolic excursion (TAPSE), routinely used in the assessment of RV function. Preoperative RV dysfunction measured with TAPSE and right ventricular fractional area change (RVFAC) has been shown to be predictors of increased mortality and morbidity after cardiac surgery [2, 3] . A reduction in TAPSE after surgical aortic valve replacement (SAVR), but not after transcatheter aortic valve replacement (TAVR), has been observed [4] . Little is known about the mechanism behind this. Randomized trials, indicating how much of this effect is caused by the procedure itself, are very limited as TAVR is predominantly offered to patients at high surgical risk [5] . It has never been investigated in a randomized set-up whether these changes are present in low-risk patients too.
Only few studies investigating long-term development in RV echocardiographic parameters after cardiac surgery exist. One study has assessed long-term effects of coronary artery bypass grafting (CABG) surgery on TAPSE, and it found that TAPSE was reduced up to 1 year [6] . This is in line with two studies, demonstrating that tricuspid annular velocities by pulsed wave tissue Doppler were reduced 1 year after CABG [7, 8] . Recent studies have hypothesized that increased transverse contraction in the RV preserves global systolic function; therefore, the reduction in TAPSE does not reflect reduced myocardial contractility per se [9, 10] . The RV function is known to be pressure sensitive, and will adapt in case of continuous pressure overload with hypertrophy and increased transverse contraction [11, 12] . Using TEE, Unsworth et al. have shown that RV long axis velocities, measured with pulsed wave tissue Doppler, fall within 3 min of incision of the pericardium [13] . It is possible that the change in RV longitudinal velocity seen after pericardial opening is caused by altered contraction patterns rather than myocardial damage. Hence, two key questions still need answering, regarding the interpretation of echocardiographic signs of RV impairment: (i) whether they truly reflect reduced RV function or just a change in contraction pattern and thereby a new basis for the echocardiographic evaluation, and (ii) whether these findings are permanent or normalize over time.
The aim of this study was, therefore, to characterize RV function, using well-established echocardiographic measures of both longitudinal (TAPSE) and transverse (RVFAC) contraction before and after aortic valve replacement in intermediate-and low-risk patients, randomized to open-heart or transcatheter aortic valve replacement. Furthermore, this study evaluated whether observed echocardiographic changes persisted and were associated with functional outcomes.
METHODS
This was a post hoc analysis of data from a multicentre, randomized, unblinded clinical trial, the Nordic Aortic Valve Intervention (NOTION) trial, where patients with isolated severe aortic valve stenosis (AS) were randomized to SAVR or TAVR in a 1:1 ratio. The study protocol was accepted by the regional ethics committee and in accordance with the Helsinki Declaration. All patients provided written informed consent. The trial is registered at clinicaltrials.gov (NCT01057173). Detailed trial information can be found elsewhere [14, 15] .
Patients
Patients in the NOTION trial had to be ≥70 years of age with severe degenerative AS, and considered to be candidates for both SAVR and TAVR, regardless of their predicted post-procedure mortality risk. Detailed information on inclusion and exclusion criteria can be found elsewhere [14, 15] . A subset of patients from the NOTION trial (single centre covering 80%) were examined using a specific echocardiographic protocol before the procedure and after 3 and 12 months. These patients were included in the present substudy.
Valve replacement procedure
The TAVR group received the CoreValve self-expanding bioprosthesis (Medtronic Inc., Minneapolis, MN, USA) in sizes 23, 26, 29 or 31 mm using predominantly transfemoral access (96.5%) and otherwise the trans-subclavian route (3.5%). Transapical TAVR was not performed. The procedure was performed in general anaesthesia. Rapid RV pacing and balloon valvuloplasty were used, but no cardiopulmonary bypass (CPB) was required. [14] .
Echocardiographic assessment
A specific TTE protocol was performed in accordance with current guidelines by trained echocardiographic technicians, using IE33 Philips Sonos ultrasound machines equipped with a 5S-probe (Philips Medical Systems, Andover, MA, USA). The examinations were performed at baseline and at 3 and 12 months postprocedure. The echocardiography included M-mode, twodimensional apical four-chamber views and continuous wave Doppler estimated peak systolic tricuspid pressure gradients. Using random numbers TAPSE and RVFAC measurements were analysed with blinding of the individual time points. TAPSE was measured in M-mode in the apical four-chamber view, and RVFAC and continuous wave Doppler velocities estimated peak systolic tricuspid pressure gradients were similarly measured in the apical four-chamber view. TAPSE was measured on all patients by one of two investigators, and RVFAC was measured by one investigator. The quality of the four-chamber views for RVFAC measurements was graded on an arbitrary scale from 1 to 3. A clear endocardial border was graded as 1; if the endocardial border was less distinct, it was graded as 2 and if the RV border was difficult to visualize or not visible, it was graded as 3. All grade 3 scans were excluded from the study.
Left ventricular ejection fraction (LVEF) was measured using the modified Simpson's method [16] . To assess LV longitudinal contraction, atrioventricular plane displacement (AVPD) was measured in the apical four-chamber view at the lateral and septal AV-plane. In the two-chamber view, the anterior and inferior AV displacement was assessed. AVPD was defined as the displacement of the plane at the four sites from end-systole to enddiastole [17] . Some of the patients had poor acoustic windows at follow-up visits, which is reflected as missing values in some of the variables, particularly at 3 months follow-up.
To assess intraobserver variability of RVFAC and TAPSE, 20 scans were re-evaluated by the same observer after 1 month. To assess interobserver variability of RVFAC, 20 scans (grade 1 and 2) were evaluated by a third investigator. Interobserver variability of TAPSE was assessed using 10 random scans assessed by two independent investigators.
Statistical methods
Statistical analyses were performed using SPSS (IBM SPSS statistics, version 22.0, Armonk, New York, USA or SAS software, version 9.4, SAS Institute Inc., Cary, NC, USA). Normal distribution was evaluated using histograms and Q-Q plots. Data are reported as either mean ± standard deviation (SD), mean ± standard error of the mean (SEM) or median and 25th and 75th percentiles. Means between treatment groups at the same time points were compared using Student's t-test for unpaired data with Bonferroni correction for multiple comparisons, and means for the same patients at different time points were compared using Student's t-test for paired data. Wilcoxon-signed rank test was used for paired data that were not normally distributed. Longitudinal measurements determined at baseline, 3 months and 12 months postoperatively were evaluated, using a repeated measurements linear model with time and treatment group as fixed effects. A treatment:time interaction term was included. Overall effect of the treatment group was evaluated using a random-intercepts, constrained linear mixed model with unstructured covariance with time as fixed effect. The constrained model included adjustment for baseline differences assuming that group means were equal at baseline due to the randomized design. When analysing AVPD, adjustments were made for left bundle branch block (LBBB) and pacemaker at baseline. Categorical variables were compared using χ 2 or Fisher's exact test if the expected frequency was under five. Intra-and interobserver variability was assessed using intraclass correlation coefficients (ICC). In line with previous studies, an ICC below 0.70 was considered poor, 0.80 good, 0.90 excellent and 1.0 perfect reproducibility [18] .
All tests were two-sided, and P < 0.05 was considered significant.
RESULTS
A total of 232 patients were examined by the echocardiographic protocol, and all patients were from Rigshospitalet, University Hospital of Copenhagen. After randomization, before valve replacement, three patients in the TAVR group and one patient in the SAVR group died. Four patients withdrew their consent. Two patients randomized to TAVR were converted to SAVR, and two patients randomized to SAVR were converted to TAVR and aortic valve bypass. These 12 patients were excluded. 
Reproducibility
Intraobserver variability analysis yielded good reproducibility for RVFAC measured on quality 1 and 2 scans (ICC = 0.87 and 0.89, respectively). The interobserver variability for RVFAC showed poor reproducibility on quality 1 and 2 scans (ICC = 0.69 and 0.64, respectively). Interobserver variability showed excellent reproducibility for TAPSE (ICC = 0.93).
Echocardiographic results
The groups had similar baseline TAPSE, RVFAC, peak systolic tricuspid pressure gradient and AVPD lateral and medial values (see Tables 2 and 3 ). Comparing TAVR vs SAVR, there were significant differences between echocardiographic measurements of RV and LV function during follow-up (Fig. 1) . TAPSE and RVFAC were unaffected by the TAVR procedure at all time points. The linear models showed that the SAVR group showed a significant decrease in TAPSE at 
Functional outcome
Patients improved their NYHA class following both TAVR and SAVR compared to baseline. After 12 months, significantly more patients in the TAVR group had dyspnoea (NYHA class I: 68% in the TAVR group vs 82% in the SAVR group, NYHA class II: 28% in the TAVR group vs 14% in the SAVR group, NYHA class III: 4% in the TAVR group vs 3% in the SAVR group). No patients were in NYHA class IV (P = 0.047).
DISCUSSION
This is the first randomized study comparing echocardiographic measures of RV function in low-risk patients after TAVR vs SAVR. We evaluated the effect of aortic valve replacement on RV function in relation to the type of procedure.
Following open-heart surgery, TAPSE, RVFAC and peak systolic tricuspid pressure gradient were reduced 3 months postoperatively. RVFAC and peak systolic tricuspid pressure gradient had partly recovered 12 months postoperatively, whereas TAPSE remained decreased. The reduction in RV longitudinal contraction for SAVR patients is consistent with previous findings [6] [7] [8] . A reduction in TAPSE following SAVR, but not after TAVR, has been observed in a small substudy based on a retrospective analysis from the Placement of AoRTic TraNscathetER Valve Trial (PARTNER) [4] . Previous studies have described a reduced TR gradient after aortic valve replacement [19] . We believe the TR-gradient largely remained unchanged after the procedure in this study due to the patients being low-risk with a normal TR-gradient at baseline. There was a temporary decrease in TR gradient in the SAVR group at 3 months, along with reduction in TAPSE and RVFAC, but it is uncertain whether this represents an actual temporary reduction in RV performance.
Data demonstrate a decrease in echocardiographic measures of RV performance during the first 3 months after surgery, but there seems to be a recovery phase of RV performance assessed with RVFAC, and this observation underlines the importance of a longtime follow-up. However, the reduction in RVFAC at 3 months is in contrast with the results from the PARTNER trial by Okada et al. which showed no postoperative change in RVFAC in the SAVR group. This discrepancy could be explained by the fact that the trial by Okada et al. included only 37 patients or because the patients they studied were high-risk patients with a lower baseline RVFAC compared to the NOTION cohort (38% (SD 12%)) [4] .
RV function is at risk of being temporarily compromised due to myocardial stunning during and after cardiac surgery with the use of cardioplegic arrest. An incomplete RV cardioplegic arrest (e.g. because of severe right coronary artery disease or misplacement of the retrograde cardioplegia catheter) will result in RV impairment postoperatively [20] . Using thermodilution and radionuclide techniques, Breisblatt et al. have shown that the initial impairment of RVEF and LVEF seen after CPB recover within 8-10 h [21] . If TAPSE is a measure of global RV function, it would be expected that TAPSE showed similar signs of recovery, but it does not. It has, however, been shown that after cardiac surgery, there is only a modest correlation between TAPSE and RV stroke volume by thermodilution, and it could, therefore, be speculated that TAPSE due to its one-dimensional evaluation of RV function is not a sensitive measure of RV function after cardiac surgery and may merely reflect changes in the physiological condition during echocardiographic evaluation [22, 23] . In this context, an almost immediate reduction in TAPSE has been observed after pericardial opening during cardiac surgery [13] .
Data on aortic valve performance have been published in detail elsewhere. Both groups showed improvements in mean aortic valve gradient and effective orifice area from baseline. The TAVR patients had lower mean aortic valve gradients and larger effective orifice area compared to SAVR patients after 1 year, but more aortic valve regurgitation [15] . Neither measures of LV function nor measures of RV function (TAPSE and RVFAC) were associated to NYHA class in either group (data not shown). The TAVR patients had a higher median NYHA class after 1 year compared to the SAVR group, despite the fact that there were more patients with aortic regurgitation in the TAVR group. Since NYHA is an overall rough measure of cardiac function, including both left and right ventricular performance, any conclusive deduction regarding RV echocardiographic measurements cannot be reached. Owing to these considerations, changes in NYHA class were not investigated in individual patients, but only at group level.
Eight patients died in the SAVR group compared to four patients in the TAVR group, as previously reported this difference was not statistically significant [15] . It is likely that the reduction in TAPSE after cardiac surgery observed in the present study does not indicate a haemodynamic reduction in RV global systolic function, and therefore does not translate into symptomatic functional changes. This is supported by the fact that RVFAC recovers at 1-year follow-up. Previous studies have also observed a reduction in TAPSE following SAVR, whereas TAPSE remains unaffected after TAVR [24, 25] . In a non-randomized study, Keyl et al. used 3D echocardiography to investigate RV changes after TAVR and SAVR. In accordance with our results, they found a decrease in RV longitudinal contraction, but an increase in RV transverse contraction after SAVR, but no change in either parameter after TAVR. RV ejection fraction was also preserved after both SAVR and TAVR [9] . RV contraction is a complex composite of longitudinal and transverse contractions, and it has previously been shown that the contraction pattern of the RV changes with pericardial opening from predominantly longitudinal to transverse contraction [4, 13, 26] . Changes in contraction pattern after SAVR could be caused by the pericardiotomy and the resulting changes in the suspensory apparatus, i.e. the pericardium and pericardial ligaments. If the pericardium is not closed after SAVR, pericardial adhesions will form and normal mediastinal anatomy will not be restored. This may explain the continued decrease in TAPSE and abnormal contraction pattern.
There was an increase in AVPD lateral after 3 and 12 months and a small increase in LVEF, but no change in AVPD medial compared to baseline. The reduced TAPSE accompanied by an increase in lateral AVPD could indicate an increased counterclockwise rotation of the entire heart. Longitudinal rotation, a clockwise or counter-clockwise rotation of the heart during systole, is known to affect both TAPSE and lateral AVPD but not medial AVPD [27, 28] . It is previously shown that lateral AVPD increases after SAVR and TAVR [24, 29] . It is therefore possible that the increase in lateral AVPD group stems partly from longitudinal rotation rather than increased contractility and the reason we did not find a significant increase in lateral AVPD after TAVR is because the heart's suspensory apparatus is left intact. Although lateral AVPD was increased 3 and 12 months postoperative, LVEF was not significantly increased until after 12 months. The clinical impact of this minor increase is, however, questionable.
Study strengths and limitations
Owing to the randomized design, the present study was the first, where the influence of two aortic valve replacement techniques could be compared directly with respect to RV echocardiographic measurements in low-risk patients. Previous studies have either been observational or only studied in a limited number of randomized high-risk patients.
This study is a sub-study of the NOTION trial, and RV evaluation was not the primary aim of the study. There were no available intraoperative echocardiography data included in the study, and in that respect we can only refer to others reporting on the reduction in TAPSE observed during pericardiotomy. Since RV is pressure sensitive and affected by septal movement, aortic prosthetic valve paravalvular leakage and prosthesis-patient mismatch (PPM) could potentially affect RV function; however, our group has recently published the data on PPM from the NOTION cohort and found no clinical effect of PPM [30] . Adjustment was not done for these parameters.
We found a relatively high interobserver variability in RVFAC, which is a known problem with this variable. It is, therefore, crucial to combine RVFAC with other measurements to validate observations. On that note, we used TAPSE, known to have a low interobserver variability and at the same time TAPSE is almost always obtainable.
Caution should be made when comparing pre-and postoperative indices of RV function and should include indices of global systolic function. Relying solely on measures of longitudinal function may underestimate global systolic function. To fully characterize RV changes after surgery it is possible that using modalities with 3D capabilities such as 3D echocardiography, CT or MRI, could be superior.
CONCLUSION
This study was the first to assess RV function in a randomized set-up with low-or intermediate-risk patients to SAVR or TAVR. Three months postoperative, SAVR patients had reduced TAPSE, RVFAC and peak tricuspid pressure gradient but both RVFAC and peak systolic tricuspid pressure gradient had recovered at 12 months followup. TAPSE and AVPD lateral differed between TAVR and SAVR at 3 and 12 months follow-up, but these findings were not related to any changes in NYHA class. These observations indicate that following SAVR echocardiographic changes may not reflect right ventricular function, but merely a change in the physiological conditions.
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